Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms

Title
Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms
Authors
Keywords
peptide receptor radionuclide therapy; neuroendocrine tumors; survival; functional syndromes
Journal
Oncotarget
Volume 9, Issue 24, Pages -
Publisher
Impact Journals, LLC
Online
2018-02-17
DOI
10.18632/oncotarget.24524

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now